Marc Dooms
- Economics and Econometrics top 5%
- Pediatrics, Perinatology and Child Health top 10%
- Genetics
- Dermatology top 5%
- Molecular Biology
- Co-authors
- Steven SimoensDavid CassimanEline PicavetMaria Helena Catelli de CarvalhoA. Dooms‐GoossensIsabelle HuysEline van OverbeekeH. Degreef
- Topics
- Health Systems, Economic Evaluations, Quality of Life (22 papers)Pharmaceutical Economics and Policy (18 papers)Pharmaceutical studies and practices (16 papers)
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Marc Dooms
47 papers receiving 607 citations
Peers
Comparison fields: 5 of 102
- Economics and Econometrics 206
- Pediatrics, Perinatology and Child Health 137
- Genetics 126
- Dermatology 114
- Molecular Biology 76
Countries citing papers authored by Marc Dooms
This map shows the geographic impact of Marc Dooms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Dooms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Dooms more than expected).
Fields of papers citing papers by Marc Dooms
This network shows the impact of papers produced by Marc Dooms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Dooms. The network helps show where Marc Dooms may publish in the future.
Co-authorship network of co-authors of Marc Dooms
This figure shows the co-authorship network connecting the top 25 collaborators of Marc Dooms. A scholar is included among the top collaborators of Marc Dooms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Dooms. Marc Dooms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | 4 | |
| 8 | 19 | |
| 9 | 3 | |
| 10 | 24 | |
| 11 | 31 | |
| 12 | 5 | |
| 13 | 10 | |
| 14 | 85 | |
| 15 | 49 | |
| 16 | How much is the life of a cancer patient worth? A pharmaco-economic perspective | 1 |
| 17 | 4 | |
| 18 | Drugs for rare diseases – influence of orphan designation status on price | 0 |
| 19 | 1 | |
| 20 | 25 |
About Marc Dooms
Marc Dooms is a scholar working on Dermatology, Pediatrics, Perinatology and Child Health and Economics and Econometrics, having authored 50 papers that have together received 630 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Pharmaceutical Economics and Policy (18 papers) and Pharmaceutical studies and practices (16 papers). The work is most often cited by research in Dermatology (114 citations), Economics and Econometrics (206 citations) and Pediatrics, Perinatology and Child Health (137 citations). Marc Dooms has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Steven Simoens, David Cassiman, Eline Picavet, Maria Helena Catelli de Carvalho, A. Dooms‐Goossens, Isabelle Huys, Eline van Overbeeke, H. Degreef, Annemieke Aartsma‐Rus and Yann Le Cam. Their work appears in journals such as Drugs, Drug Discovery Today and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.